Disease Info Card

Metastatic Renal Cell Cancer

Information about Metastatic Renal Cell Cancer: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Metastatic Renal Cell Cancer

Most recent studies have shown that Metastatic Renal Cell Cancer shares some biological mechanisms with adenocarcinoma, bone-neoplasms, carcinoma, diarrhea, hemorrhage, hypertensive-disease, kidney-neoplasm, lung-neoplasms, malignant-neoplasm-of-kidney, malignant-neoplasms, malignant-paraganglionic-neoplasm, melanoma, metastatic-malignant-neoplasm-to-the-lung, nausea, neoplasm-metastasis, neoplasms, pain, primary-neoplasm, renal-cell-carcinoma, tumor-angiogenesis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Metastatic Renal Cell Cancer, and have been seen in publications frequently: Angiogenesis, Cell Activation, Cell Adhesion, Cell Cycle, Cell Death, Cell Differentiation, Cell Growth, Cell Proliferation, Coagulation, Cytolysis, Dehiscence, Drug Resistance, Excretion, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Pathogenesis, Response To Interleukin-2, Secretion

Quite a number of genes have been found to play important roles in Metastatic Renal Cell Cancer, such as ALPK1, CA9, CRP, IFNA1, IFNG, IL2, IL6, MID1, MME, MTOR, PGR, RANGAP1, SLC17A5, TMEM37, TNF, VEGFA, XRCC1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.